NASDAQ · CCAP
Crescent Capital BDC financials
$9.54+0.42%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $134.9M | $182.0M | $185.4M | $72.5M | $130.0M | $81.9M |
| Gross profit | $77.4M | $119.2M | $126.7M | $40.7M | $110.2M | $66.4M |
| Gross margin | 57.4% | 65.5% | 68.3% | 56.0% | 84.8% | 81.1% |
| Operating income | $36.2M | $75.2M | $85.1M | $15.7M | $85.9M | $55.2M |
| Net income | $34.5M | $73.6M | $83.8M | $15.5M | $83.6M | $54.7M |
| Net margin | 25.6% | 40.5% | 45.2% | 21.4% | 64.3% | 66.8% |
| Diluted EPS | $0.93 | $1.99 | $2.33 | $0.50 | $2.94 | $1.98 |
| EBITDA | $36.2M | $75.2M | $85.1M | $15.7M | $85.9M | $55.2M |
| Operating cash flow | $74.7M | $58.9M | $92.3M | $28.0M | -$157.7M | -$61.8M |
| Free cash flow | $74.7M | $58.9M | $92.3M | $28.0M | -$157.7M | -$61.8M |
| Diluted shares | 37.0M | 37.1M | 35.9M | 30.9M | 28.5M | 27.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $5.0M | $10.1M | $7.8M | $6.4M | $10.1M |
| Short-term investments | $1.60B | $1.63B | $1.60B | $1.28B | $1.28B |
| Total debt | $886.1M | $875.8M | $844.8M | $662.9M | $636.6M |
| Total assets | $1.62B | $1.66B | $1.63B | $1.30B | $1.32B |
| Total liabilities | $916.1M | $915.6M | $884.8M | $690.3M | $665.5M |
| Shareholders' equity | $706.0M | $740.6M | $742.6M | $612.5M | $652.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology